Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
04/12/2012 | WO2012048249A1 Site-specific incorporation of phosphoserine into proteins in escherichia coli |
04/12/2012 | WO2012048221A1 Closterovirus-based nucleic acid molecules and uses thereof |
04/12/2012 | WO2012048213A1 A method to increase gene targeting frequency |
04/12/2012 | WO2012048207A2 Compositions and methods for nucleic acid based diagnostic assays |
04/12/2012 | WO2012048113A2 Biomarkers of cancer |
04/12/2012 | WO2012048106A2 Biomarkers useful to predict mek inhibitor drug efficacy |
04/12/2012 | WO2012047970A1 Regulatory factors controlling oil biosynthesis in microalgae and their use |
04/12/2012 | WO2012047956A2 Treatment of sialidase 4 (neu4) related diseases by inhibition of natural antisense transcript to neu4 |
04/12/2012 | WO2012047899A2 Novel dna hypermethylation diagnostic biomarkers for colorectal cancer |
04/12/2012 | WO2012047897A2 Processes and compositions for detecting human papilloma virus types |
04/12/2012 | WO2012047732A2 Antibody compositions and methods of use |
04/12/2012 | WO2012047595A2 Maize cytoplasmic male sterility (cms) c-type restorer rf4 gene, molecular markers and their use |
04/12/2012 | WO2012047584A2 Macaca fascicularis ccl17 |
04/12/2012 | WO2012047583A2 Antibodies binding human collagen ii |
04/12/2012 | WO2012047324A2 Systems and methods for amplification and phage display |
04/12/2012 | WO2012047267A2 Polyvalent immunogen |
04/12/2012 | WO2012047234A1 Compositions and methods for diagnosing autism |
04/12/2012 | WO2012047175A1 Fusion polypeptides comprising tir and dimerization domain for modulation of tlr/innate immunity signaling |
04/12/2012 | WO2012047099A2 Method for extracting dna from nematodes and plant cells |
04/12/2012 | WO2012047093A1 Treatment of the sjögren's syndrome |
04/12/2012 | WO2012047091A1 Glp-1 promoter mediated insulin expression for the treatment of diabetes |
04/12/2012 | WO2012047076A2 Latex secretory tissue-specific srpp promoter derived from hevea brasiliensis and use thereof |
04/12/2012 | WO2012047015A2 Multiplex microfluidic device for selecting nucleic acid aptamers, and high throughput selection method for nucleic acid aptamers using same |
04/12/2012 | WO2012047006A2 Ggps gene for promotimg higher growth or biomass of plant and use thereof |
04/12/2012 | WO2012046981A2 Real time pcr detection of single nucleotide polymorphisms |
04/12/2012 | WO2012046946A1 Human neural stem cells expressing human choline acetyltransferase, and use thereof |
04/12/2012 | WO2012046943A2 Gene delivery system having enhanced tumor-specific expression, and recombinant gene expression regulating sequence |
04/12/2012 | WO2012046924A1 Xylitol-producing strain to which an arabinose metabolic pathway is introduced, and method for producing xylitol using same |
04/12/2012 | WO2012046874A1 Method for evaluating degree of cancerization |
04/12/2012 | WO2012046873A1 Method for evaluating degree of cancerization |
04/12/2012 | WO2012046872A1 Method for evaluating degree of cancerization |
04/12/2012 | WO2012046871A1 Method for evaluating degree of cancerization |
04/12/2012 | WO2012046859A1 Identifying information carrier for identifying subject to be identified and utilization of same |
04/12/2012 | WO2012046855A1 Method for imparting disease resistance to plant |
04/12/2012 | WO2012046836A1 Hepatitis c virus gene |
04/12/2012 | WO2012046745A1 Therapeutic agent for malignant tumors expressing mhc class ii |
04/12/2012 | WO2012046731A1 YEAST AND YEAST EXTRACT CONTAINING γ-Glu-Abu, AND METHOD FOR PRODUCING THE YEAST OR YEAST EXTRACT CONTAINING γ-Glu-Abu |
04/12/2012 | WO2012046727A1 Method for producing virus vector |
04/12/2012 | WO2012046255A2 Expression vector for high level expression of recombinant proteins |
04/12/2012 | WO2012046110A1 Polynucleotide and polypeptide sequences associated with abiotic stress responses and methods of obtaining an abiotic stress tolerant plant |
04/12/2012 | WO2012046085A2 Methods of inducing insulin production |
04/12/2012 | WO2012046006A2 Cancer targets |
04/12/2012 | WO2012045894A1 Compounds and compositions for the treatment of illnesses caused by the hepatitis b virus |
04/12/2012 | WO2012045797A1 Lipothiophosphoramidates for gene delivery |
04/12/2012 | WO2012045733A1 Reversibly photoswitchable polypeptides |
04/12/2012 | WO2012045722A1 Methods for semi-synthetically producing highly pure minicircle dna vectors from plasmids |
04/12/2012 | WO2012045286A1 Recombinant vector and fibroin membrane modified by transgenic bone stromal cell, and application thereof |
04/12/2012 | WO2012007919A3 Nucleic acid construct for increasing abiotic stress tolerance in plants |
04/12/2012 | WO2012005378A3 Dna element having the activity of enhancing foreign gene expression |
04/12/2012 | WO2012004790A3 Nucleic acid aptamer-based detection methods characterized by signal enhancement |
04/12/2012 | WO2012003493A3 Protein kinase ck2 gene mutations, amplifications and polymorphisms in human cancers and methods of use |
04/12/2012 | WO2012002775A3 Asthma diagnosis using the neuropilin-1 gene, and method for screening for a therapeutic agent for asthma |
04/12/2012 | WO2011163526A3 Signal activated molecular delivery |
04/12/2012 | WO2011163499A3 Treatment of sodium channel, voltage-gated, alpha subunit (scna) related diseases by inhibition of natural antisense transcript to scna |
04/12/2012 | WO2011162492A3 Fusion protein comprising small heat shock protein, cage protein formed thereby, and novel use thereof |
04/12/2012 | WO2011159924A3 Compositions and methods for identifying and modifying carbonaceous compositions |
04/12/2012 | WO2011156434A3 Nucleic acid detection and quantification by post-hybridization labeling and universal encoding |
04/12/2012 | WO2011153344A3 Engineering complex microbial phenotypes with transcription enhancement |
04/12/2012 | WO2011153342A3 Engineering complex microbial phenotypes with successive integrations of exogenous dna (siedna) |
04/12/2012 | WO2011153323A8 Compositions and methods directed to treating liver fibrosis |
04/12/2012 | WO2011153276A3 Stable, functional chimeric cellobiohydrolase class i enzymes |
04/12/2012 | WO2011152884A9 14 gene signature distinguishes between multiple myeloma subtypes |
04/12/2012 | WO2011150082A9 Methods of utilizing the arrestin-2/stam-1 complex as a therapeutic target |
04/12/2012 | WO2011142646A9 Method for detecting hpv (human papilloma virus) and genotype thereof |
04/12/2012 | WO2011132989A3 Methylation marker for diagnosis of cervical cancer |
04/12/2012 | WO2011130650A3 Antibodies for the treatment of clostridium difficile-associated infection and disease |
04/12/2012 | WO2011113004A3 Markers associated with alzheimer's disease |
04/12/2012 | WO2011109548A3 Microbial engineering for the production of fatty acids and fatty acid derivatives |
04/12/2012 | WO2011100477A3 Antibodies and processes for preparing the same |
04/12/2012 | WO2011087782A8 Compositions, kits and methods for detection of trypanosoma cruzi using loop-mediated isothermal amplication |
04/12/2012 | WO2011082281A3 Treatment of insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to irs2 and transcription factor e3 (tfe3) |
04/12/2012 | WO2011080301A3 Strains and method for the production of methionine |
04/12/2012 | WO2011067711A3 Novel heparanase splice variant |
04/12/2012 | WO2004076638A8 Polynucleotides and polypeptides in plants |
04/12/2012 | US20120090054 Polypeptides having endoglucanase activity and polynucleotides encoding same |
04/12/2012 | US20120090052 Plants Having Enhanced Yield-Related Traits And A Method For Making The Same |
04/12/2012 | US20120090051 Plants containing a heterologous flavohemoglobin gene and methods of use thereof |
04/12/2012 | US20120090050 Generation of plants with altered protein, fiber, or oil content |
04/12/2012 | US20120090049 Seed specific usp promoters for expressing genes in plants |
04/12/2012 | US20120090048 Root specific expression promoter from capsicum annuum aquaporin gene and uses thereof |
04/12/2012 | US20120090047 Maize cytoplasmic male sterility (cms) c-type restorer rf4 gene, molecular markers and their use |
04/12/2012 | US20120090046 Zantedeschia Variety 110067-52451 |
04/12/2012 | US20120090044 Indoleamine 2,3-Dioxygenase-2 |
04/12/2012 | US20120090043 Targets for retrovirus associated diseases |
04/12/2012 | US20120090042 Polypeptides Having Phytase Activity And Polynucleotides Encoding Same |
04/12/2012 | US20120088819 Method for enhancing expression of recombinant protein |
04/12/2012 | US20120088817 Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene |
04/12/2012 | US20120088813 Anti viral therapy |
04/12/2012 | US20120088718 Hcv-derived polypeptides and uses thereof |
04/12/2012 | US20120088717 Method for treating fungal infection with antifungal bifunctional molecules |
04/12/2012 | US20120088715 Mutated antithrombins, a process for preparing the same and their use as drugs |
04/12/2012 | US20120088695 Method and Device for Protein Delivery into Cells |
04/12/2012 | US20120088677 Methods and compositions for analysis of regulatory sequences |
04/12/2012 | US20120088304 Methods of generating cells exhibiting phenotypic plasticity |
04/12/2012 | US20120088301 Factor taking part in transcription control |
04/12/2012 | US20120088298 Ikkalpha and ikkbeta specific inhibitors |
04/12/2012 | US20120088297 Mycobacterial antigens expressed under low oxygen tension |
04/12/2012 | US20120088289 Vmp-like sequences of pathogenic borrelia species and strains |
04/12/2012 | US20120088288 Subtilases |
04/12/2012 | US20120088281 Thiolase with Improved Activity and Method of Producing Biobutanol Using the Same |